We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Kalexsyn and BioRelix Announce Extension of Collaboration to Identify Anti-Bacterial Drug Candidates

Product News   Mar 26, 2011

 
Kalexsyn and BioRelix Announce Extension of Collaboration to Identify Anti-Bacterial Drug Candidates
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Rentschler Biopharma and Vetter Team Up to Optimize Time-To-Market

Product News

Vetter and Rentschler Biopharma have announced their strategic collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.

READ MORE

Cobra Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate

Product News

Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, has announced it has signed a supply agreement with AstraZeneca UK Ltd. (“AstraZeneca”) to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222,

READ MORE

Delta 4 Announces Results Achieved With Drug Discovery Platform

Product News

Delta 4 has announced recent results achieved in two drug discovery and development programs, involving kidney disease and COVID-19.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE